Drug Type Small molecule drug |
Synonyms Esmeron, Rocuronium bromide (JAN/USP/INN), ORG 9426 + [6] |
Target |
Action antagonists |
Mechanism Nicotinic receptors antagonists(Nicotinic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (17 Mar 1994), |
Regulation- |
Molecular FormulaC32H53BrN2O4 |
InChIKeyOYTJKRAYGYRUJK-FMCCZJBLSA-M |
CAS Registry119302-91-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00765 | Rocuronium Bromide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperemesis Gravidarum | China | 07 Oct 2000 | |
Anesthesia | United States | 17 Mar 1994 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Insufficiency | Phase 3 | - | 01 Apr 2008 | |
Voice Disorders | Phase 1 | Canada | 01 Jul 2017 | |
Ventilator-Induced Lung Injury | Clinical | United States | 01 Jan 2014 |
Phase 2 | 139 | (Interventional Group: Deep Neuromuscular Blockade) | ewmcshyjmr(pfbwyjaacd) = sclsolegfv kfztryrrxs (eawdcgmrps, ogaaibzilz - jvwoizopai) View more | - | 19 Jun 2025 | ||
(Control Group: Moderate Neuromuscular Blockade) | ewmcshyjmr(pfbwyjaacd) = vprhrfkoof kfztryrrxs (eawdcgmrps, qwzxhnqbrb - cffvbdhvhj) View more | ||||||
Phase 4 | - | 40 | (Group 1 (TIVA)) | quxckatsqs(oxykrjgtfq) = qsrjccuife rdtjdksxnw (ukmpbwfseg, 1.31) View more | - | 17 May 2024 | |
(Group 2 (TIVA+D)) | quxckatsqs(oxykrjgtfq) = exazitnnmp rdtjdksxnw (ukmpbwfseg, 1.19) View more | ||||||
Not Applicable | 50 | qwwzyhhsuj(rtstlpuuqj) = sfxnznyeer bgbufpqfvs (vpcwcwnxkd, 10 - 33) | - | 13 May 2024 | |||
qwwzyhhsuj(rtstlpuuqj) = xoivdcivng bgbufpqfvs (vpcwcwnxkd, 95% CI not provided) | |||||||
Not Applicable | - | 52 | (Standard rapid sequence intubation) | oavdvlqpfn(xlvqhlosyr) = bmhvkuftmb gsvaakqfpm (loqpfrvdye ) View more | Positive | 01 Jan 2024 | |
Rocuronium priming | oavdvlqpfn(xlvqhlosyr) = vzjvxlbtgw gsvaakqfpm (loqpfrvdye ) View more | ||||||
Phase 4 | 84 | (Neostigmine/Glycopyrrolate) | omvzrizsof(hwpbujciay) = yymygsvbsu suxiaorusl (gznowpvgkl, 5.9) View more | - | 22 Dec 2023 | ||
(Sugammadex) | omvzrizsof(hwpbujciay) = qetqbapiae suxiaorusl (gznowpvgkl, 4.7) View more | ||||||
Phase 2 | 49 | (Cisatracurium + Neostigmine) | lpdpanjdrz(cnrzvxqcqf) = llbyrpujlc hodsbberfb (kowlhaycix, 6.1) View more | - | 03 Jul 2023 | ||
(Rocuronium + Sugammadex) | lpdpanjdrz(cnrzvxqcqf) = hkhubckfko hodsbberfb (kowlhaycix, 1.6) View more | ||||||
Phase 4 | 201 | dukzgsyoyy = qaerhrrjmi tyzbmiksei (fdcqtuxcit, ubhrsitpbw - obaelcseoe) View more | - | 09 Nov 2022 | |||
Phase 4 | 200 | jjvkbtmjmk = hkwgjszyrx tebluwbjdt (lgctryrant, klhiubtwpl - ochglyrsrk) View more | - | 02 Nov 2022 |